Optimys Femoral Stem for Total Hip Replacement
Optihip
1 other identifier
observational
453
1 country
1
Brief Summary
This retrospective observational study analyses the surgical performance, clinical and radiologic outcome as well as the rate of infections with a main focus on revision surgeries after primary implantation of the Optimys short stem femoral prosthesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 16, 2019
CompletedFirst Submitted
Initial submission to the registry
May 6, 2019
CompletedFirst Posted
Study publicly available on registry
May 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2021
CompletedJune 15, 2021
June 1, 2021
2.2 years
May 6, 2019
June 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
rate of reoperations
rate of reoperations after primary implantation of the Optimys short stem prosthesis
one year follow-up period after Optimys femoral stem surgery
Secondary Outcomes (10)
rate of cortical hypertrophy
at one year follow-up after Optimys femoral stem surgery
rate of fractures
one year follow-up period after Optimys femoral stem surgery
rate of infections
one year follow-up period after Optimys femoral stem surgery
anatomic alignment on anterior-posterior (ap) view in Degree°
at one year follow-up after Optimys femoral stem surgery
subsidence
at one year follow-up after Optimys femoral stem surgery
- +5 more secondary outcomes
Interventions
retrospective analysis of surgical performance, clinical and radiologic outcome
Eligibility Criteria
Patients treated for a proximal femoral fracture at the University Hospital Basel between 29.10.2013 (date of introduction of the Optimys femoral component at the university hospital Basel) and 29.10.2018.
You may qualify if:
- Patients treated with an Optimys femoral component at the University Hospital Basel between 29.10.2013 and 29.10.2018
You may not qualify if:
- Clinical follow up at another Institution
- Documented dissent in study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Orthopaedics and Trauma Surgery (DOTS).
Basel, 4031, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Clauss, Dr. med
University Hospital, Basel, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2019
First Posted
May 16, 2019
Study Start
April 16, 2019
Primary Completion
June 9, 2021
Study Completion
June 9, 2021
Last Updated
June 15, 2021
Record last verified: 2021-06